Evaluation Of Glioblastoma Tumor Microenvironment After Treatment With Pembrolizumab.

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 2|浏览13
暂无评分
摘要
2559Background: Neoadjuvant pembrolizumab improved outcome of patients with recurrent Glioblastoma (GBM) in two early phase clinical trials. However, several large phase II/III studies in patients ...
更多
查看译文
关键词
glioblastoma tumor microenvironment,pembrolizumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要